Transvaginal ultrasound (TVS) reveals a dynamic change in the cervix, from an initially normal image to a funnel. Such a transformation is one of the predictors of preterm birth that author James T. Kurtzman, MD, describes in the Contemporary OB /GYN September 2011 cover story, ?PTB: 3 Keys to Assessing Risk.? (Video courtesy of Joshua A. Copel, MD.)
Transvaginal ultrasound (TVS) reveals a dynamic change in the cervix, from an initially normal image to a funnel. Such a transformation is one of the predictors of preterm birth that author James T. Kurtzman, MD, describes in the Contemporary OB /GYN September 2011 cover story, “PTB: 3 Keys to Assessing Risk.” Click here to read the article (Video courtesy of Joshua A. Copel, MD.)
Tebipenem HBr cUTI trial ends early after meeting efficacy goals
May 28th 2025GSK and Spero Therapeutics announced that the phase 3 PIVOT-PO trial for tebipenem HBr, a potential first oral carbapenem for cUTIs in the United States, was stopped early because of positive efficacy results.
Read More